Inhibition of angiogenesis, tumour growth and experimental metastasis of human fibrosarcoma cells HT1080 by a multimeric form of the lamimin sequence Tyr-lle-Gly-Ser-Arg (YIGSR)
1996

Inhibition of Tumor Growth and Metastasis by a Peptide

Sample size: 10 publication Evidence: high

Author Information

Author(s): Y Iwamoto, M Nomizu, Y Yamada, Y Ito, K Tanaka, Y Sugioka

Primary Institution: Kyushu University; National Institute of Dental Research, National Institutes of Health

Hypothesis

Does the multimeric peptide Ac-Y16 inhibit angiogenesis, tumor growth, and metastasis of human fibrosarcoma cells HT1080?

Conclusion

The multimeric peptide Ac-Y16 significantly inhibits angiogenesis, tumor growth, and experimental metastasis more effectively than its monomeric counterpart.

Supporting Evidence

  • Ac-Y16 completely inhibited lung colonization by HT1080 cells.
  • Ac-Y16 reduced angiogenesis by 92% and tumor growth by 76%.
  • Intraperitoneal administration of Ac-Y16 was effective in inhibiting tumor growth.

Takeaway

A special peptide called Ac-Y16 helps stop cancer cells from growing and spreading in mice.

Methodology

Mice were injected with HT1080 cells and Ac-Y16 peptide to assess its effects on tumor growth and metastasis.

Limitations

The study was conducted in mice, and results may not directly translate to humans.

Participant Demographics

Female 6-week-old Balb/c nu/nu mice and female 5-week-old DDD mice were used.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication